Nov. 16, 2017	Teijin Pharma and SRETT Sign Exclusive Distribution Agreement for Respiratory Remote-monitoring Device
Oct. 26, 2017	Teijin Nakashima Medical to Acquire Spinal-related Business of Century Medical
Oct. 16, 2017	Teijin Acquires Exclusive Sales Rights to Transcranial Magnetic Stimulation Device in Japan
Oct. 12, 2017	Teijin Signs Exclusive License and Co-Development Agreement for Novel Botulinum Toxin in Japan
Jul. 18, 2017	JCR and Teijin to Develop Allogeneic Regenerative Medical Product Using Dental Pulp Stem Cells (DPCs)
Jul. 03, 2017	Somatuline® Autogel® 120 mg receives Japanese approval for a new indication for the treatment of gastro-entero-pancreatic neuroendocrine tumors
May. 26, 2017	Teijin Pharma to Enter into Worldwide License Agreement with Merck & Co., Inc., for Investigational Antibody Candidate Targeting Tau

Page Top